Total Payments
$71,113
2024 Payments
$9,709
Companies
81
Transactions
1,138
Medicare Patients
1,760
Medicare Billing
$696,270
Payment Breakdown by Category
Other$25,038 (35.2%)
Food & Beverage$22,261 (31.3%)
Consulting$16,275 (22.9%)
Travel$5,824 (8.2%)
Education$1,714 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,261 | 1,066 | 31.3% |
| Consulting Fee | $16,275 | 7 | 22.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,594 | 13 | 19.1% |
| Honoraria | $11,444 | 6 | 16.1% |
| Travel and Lodging | $5,824 | 25 | 8.2% |
| Education | $1,714 | 17 | 2.4% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$71,113
1,134 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $21,549 | 85 | $0 (2024) |
| MDD US Operations, LLC | $11,287 | 48 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $6,882 | 32 | $0 (2021) |
| Amneal Pharmaceuticals LLC | $6,780 | 82 | $0 (2024) |
| Kyowa Kirin, Inc. | $3,725 | 24 | $0 (2024) |
| Medtronic USA, Inc. | $3,281 | 34 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $1,432 | 67 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $1,234 | 60 | $0 (2022) |
| UCB, Inc. | $1,191 | 56 | $0 (2024) |
| ABBVIE INC. | $1,184 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,709 | 159 | Amneal Pharmaceuticals LLC ($5,385) |
| 2023 | $25,122 | 205 | Neurocrine Biosciences, Inc. ($12,570) |
| 2022 | $10,763 | 218 | Neurocrine Biosciences, Inc. ($3,546) |
| 2021 | $14,799 | 198 | Adamas Pharmaceuticals, Inc. ($6,627) |
| 2020 | $2,710 | 106 | Sunovion Pharmaceuticals Inc. ($957.31) |
| 2019 | $1,923 | 76 | Acorda Therapeutics, Inc ($226.92) |
| 2018 | $2,354 | 109 | Medtronic USA, Inc. ($414.53) |
| 2017 | $3,733 | 67 | Medtronic USA, Inc. ($2,413) |
All Payment Transactions
1,138 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Neurology | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Honoraria | Cash or cash equivalent | $3,029.00 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Genetic Disease | ||||||
| 12/16/2024 | Amneal Pharmaceuticals LLC | ONGENTYS (Drug) | Travel and Lodging | In-kind items and services | $879.06 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $48.03 | General |
| Category: Neurology | ||||||
| 12/10/2024 | CATALYST PHARMACEUTICALS, INC. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.87 | General |
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: AMANTADINE | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $44.25 | General |
| Category: Neurology | ||||||
| 11/05/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $44.98 | General |
| Category: Neurology | ||||||
| 11/04/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Neurology | ||||||
| 10/30/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $5.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Neuropsychiatry | ||||||
| 10/28/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Neurology | ||||||
| 10/25/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Neurology | ||||||
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 519 | 19,380 | $508,987 | $266,963 |
| 2022 | 15 | 434 | 16,163 | $397,220 | $200,895 |
| 2021 | 13 | 402 | 11,224 | $213,336 | $107,862 |
| 2020 | 12 | 405 | 2,618 | $244,594 | $120,550 |
Total Patients
1,760
Total Services
49,385
Medicare Billing
$696,270
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2023 | 20 | 3,160 | $205,400 | $120,568 | 58.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 23 | 15,500 | $148,800 | $75,651 | 50.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 106 | $21,200 | $12,781 | 60.3% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 18 | 66 | $31,250 | $9,523 | 30.5% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 17 | 17 | $16,847 | $8,270 | 49.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 17 | 17 | $15,334 | $7,742 | 50.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $10,450 | $6,107 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 60 | 66 | $9,900 | $6,006 | 60.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $10,125 | $4,615 | 45.6% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 38 | 38 | $13,300 | $4,230 | 31.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 23 | 38 | $8,360 | $3,713 | 44.4% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 17 | 57 | $5,700 | $3,387 | 59.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 32 | 47 | $5,875 | $2,295 | 39.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 21 | 64 | $3,392 | $1,009 | 29.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 25 | 26 | $1,560 | $645.59 | 41.4% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 11 | 33 | $1,122 | $390.16 | 34.8% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 32 | 62 | $372.00 | $31.53 | 8.5% |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 2022 | 11 | 2,090 | $135,850 | $73,107 | 53.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 22 | 13,506 | $129,600 | $64,698 | 49.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 104 | 141 | $28,200 | $17,341 | 61.5% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 16 | 49 | $22,750 | $7,363 | 32.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 46 | 46 | $12,650 | $7,244 | 57.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 15 | 15 | $13,530 | $6,989 | 51.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 14 | 14 | $13,874 | $6,862 | 49.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 71 | $10,650 | $5,286 | 49.6% |
About Dr. Anupama Kale, M.D
Dr. Anupama Kale, M.D is a Neurology healthcare provider based in Amherst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1467765784.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anupama Kale, M.D has received a total of $71,113 in payments from pharmaceutical and medical device companies, with $9,709 received in 2024. These payments were reported across 1,138 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($22,261).
As a Medicare-enrolled provider, Kale has provided services to 1,760 Medicare beneficiaries, totaling 49,385 services with total Medicare billing of $696,270. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Amherst, NY
- Active Since 07/15/2010
- Last Updated 02/09/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1467765784
Products in Payments
- GOCOVRI (Drug) $17,183
- INGREZZA (Drug) $13,422
- ONGENTYS (Drug) $7,430
- NOURIANZ (Drug) $3,544
- Ongentys (Drug) $3,486
- ACTIVA (Device) $3,395
- RYTARY (Drug) $1,433
- NUPLAZID (Drug) $1,234
- KYNMOBI (Drug) $1,004
- ONGENTYS 50MG CAPSULES 30 (Drug) $938.77
- Gocovri (Drug) $850.10
- BOTOX (Biological) $820.52
- AUSTEDO (Drug) $777.40
- KESIMPTA (Drug) $656.28
- NUEDEXTA (Drug) $450.12
- RADICAVA (Drug) $406.24
- Nuedexta (Drug) $390.41
- Nayzilam (Drug) $355.28
- NORTHERA (Drug) $354.15
- ONPATTRO (Drug) $339.47
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Amherst
Nicolas Saikali, Md, MD
Neurology — Payments: $1.7M
Neurology $1.7M
Dr. Jennifer Mcvige, M.d, M.D
Neurology — Payments: $1.0M
Neurology $1.0M
Bennett Myers, M.d, M.D
Neurology — Payments: $538,477
Neurology $538,477
Laszlo Mechtler, Md, MD
Neurology — Payments: $430,778
Neurology $430,778
Dr. Wisam Elmalik, M.d, M.D
Neurology — Payments: $321,171
Neurology $321,171
Dr. Bela Ajtai, Md, Phd, MD, PHD
Neurology — Payments: $135,293
Neurology $135,293